Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ZNF148
|
ENSG00000163848.14 | zinc finger protein 148 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ZNF148 | hg19_v2_chr3_-_125094093_125094198 | 0.12 | 5.2e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_+_42381173 | 2.33 |
ENST00000221972.3
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
chr19_+_42381337 | 2.26 |
ENST00000597454.1
ENST00000444740.2 |
CD79A
|
CD79a molecule, immunoglobulin-associated alpha |
chr14_-_60337684 | 2.20 |
ENST00000267484.5
|
RTN1
|
reticulon 1 |
chr17_+_37783453 | 2.17 |
ENST00000579000.1
|
PPP1R1B
|
protein phosphatase 1, regulatory (inhibitor) subunit 1B |
chr3_+_238427 | 2.16 |
ENST00000397491.2
|
CHL1
|
cell adhesion molecule L1-like |
chr19_-_42916499 | 1.90 |
ENST00000601189.1
ENST00000599211.1 |
LIPE
|
lipase, hormone-sensitive |
chr3_+_139654018 | 1.89 |
ENST00000458420.3
|
CLSTN2
|
calsyntenin 2 |
chr3_+_238273 | 1.87 |
ENST00000256509.2
|
CHL1
|
cell adhesion molecule L1-like |
chr3_+_238456 | 1.81 |
ENST00000427688.1
|
CHL1
|
cell adhesion molecule L1-like |
chr21_+_27011584 | 1.76 |
ENST00000400532.1
ENST00000480456.1 ENST00000312957.5 |
JAM2
|
junctional adhesion molecule 2 |
chr21_+_27011899 | 1.70 |
ENST00000425221.2
|
JAM2
|
junctional adhesion molecule 2 |
chr3_+_238969 | 1.66 |
ENST00000421198.1
|
CHL1
|
cell adhesion molecule L1-like |
chrX_+_13587712 | 1.60 |
ENST00000361306.1
ENST00000380602.3 |
EGFL6
|
EGF-like-domain, multiple 6 |
chr5_+_71403280 | 1.55 |
ENST00000511641.2
|
MAP1B
|
microtubule-associated protein 1B |
chr8_+_104383728 | 1.53 |
ENST00000330295.5
|
CTHRC1
|
collagen triple helix repeat containing 1 |
chr11_+_124789146 | 1.51 |
ENST00000408930.5
|
HEPN1
|
hepatocellular carcinoma, down-regulated 1 |
chr8_+_104383759 | 1.48 |
ENST00000415886.2
|
CTHRC1
|
collagen triple helix repeat containing 1 |
chr5_+_156887027 | 1.47 |
ENST00000435489.2
ENST00000311946.7 |
NIPAL4
|
NIPA-like domain containing 4 |
chr11_+_1889880 | 1.44 |
ENST00000405957.2
|
LSP1
|
lymphocyte-specific protein 1 |
chr17_-_42992856 | 1.39 |
ENST00000588316.1
ENST00000435360.2 ENST00000586793.1 ENST00000588735.1 ENST00000588037.1 ENST00000592320.1 ENST00000253408.5 |
GFAP
|
glial fibrillary acidic protein |
chr22_-_30661807 | 1.30 |
ENST00000403389.1
|
OSM
|
oncostatin M |
chr11_+_46402297 | 1.30 |
ENST00000405308.2
|
MDK
|
midkine (neurite growth-promoting factor 2) |
chr1_+_155829286 | 1.28 |
ENST00000368324.4
|
SYT11
|
synaptotagmin XI |
chr2_-_136873735 | 1.27 |
ENST00000409817.1
|
CXCR4
|
chemokine (C-X-C motif) receptor 4 |
chr10_+_17272608 | 1.27 |
ENST00000421459.2
|
VIM
|
vimentin |
chr15_-_22448819 | 1.25 |
ENST00000604066.1
|
IGHV1OR15-1
|
immunoglobulin heavy variable 1/OR15-1 (non-functional) |
chr2_+_85132749 | 1.24 |
ENST00000233143.4
|
TMSB10
|
thymosin beta 10 |
chr11_-_30038490 | 1.24 |
ENST00000328224.6
|
KCNA4
|
potassium voltage-gated channel, shaker-related subfamily, member 4 |
chr1_+_155829341 | 1.21 |
ENST00000539162.1
|
SYT11
|
synaptotagmin XI |
chr11_+_131781290 | 1.20 |
ENST00000425719.2
ENST00000374784.1 |
NTM
|
neurotrimin |
chr3_-_21792838 | 1.19 |
ENST00000281523.2
|
ZNF385D
|
zinc finger protein 385D |
chr17_-_45056606 | 1.19 |
ENST00000322329.3
|
RPRML
|
reprimo-like |
chr22_-_30662828 | 1.18 |
ENST00000403463.1
ENST00000215781.2 |
OSM
|
oncostatin M |
chr6_-_29648887 | 1.17 |
ENST00000376883.1
|
ZFP57
|
ZFP57 zinc finger protein |
chr15_+_43809797 | 1.17 |
ENST00000399453.1
ENST00000300231.5 |
MAP1A
|
microtubule-associated protein 1A |
chr19_-_15311713 | 1.15 |
ENST00000601011.1
ENST00000263388.2 |
NOTCH3
|
notch 3 |
chr9_+_34957477 | 1.15 |
ENST00000544237.1
|
KIAA1045
|
KIAA1045 |
chr11_+_46402583 | 1.14 |
ENST00000359803.3
|
MDK
|
midkine (neurite growth-promoting factor 2) |
chr9_+_34958254 | 1.13 |
ENST00000242315.3
|
KIAA1045
|
KIAA1045 |
chr22_+_22712087 | 1.10 |
ENST00000390294.2
|
IGLV1-47
|
immunoglobulin lambda variable 1-47 |
chr4_+_75480629 | 1.08 |
ENST00000380846.3
|
AREGB
|
amphiregulin B |
chr5_+_71403061 | 1.07 |
ENST00000512974.1
ENST00000296755.7 |
MAP1B
|
microtubule-associated protein 1B |
chr20_-_3748363 | 1.07 |
ENST00000217195.8
|
C20orf27
|
chromosome 20 open reading frame 27 |
chr6_+_391739 | 1.06 |
ENST00000380956.4
|
IRF4
|
interferon regulatory factor 4 |
chr14_+_22204418 | 1.05 |
ENST00000390426.2
|
TRAV4
|
T cell receptor alpha variable 4 |
chr16_-_776431 | 1.05 |
ENST00000293889.6
|
CCDC78
|
coiled-coil domain containing 78 |
chr19_-_51071302 | 1.05 |
ENST00000389201.3
ENST00000600381.1 |
LRRC4B
|
leucine rich repeat containing 4B |
chr10_+_70587279 | 1.05 |
ENST00000298596.6
ENST00000399169.4 ENST00000399165.4 ENST00000399162.2 |
STOX1
|
storkhead box 1 |
chr11_+_46402482 | 1.04 |
ENST00000441869.1
|
MDK
|
midkine (neurite growth-promoting factor 2) |
chr20_-_3748416 | 1.03 |
ENST00000399672.1
|
C20orf27
|
chromosome 20 open reading frame 27 |
chr16_-_49698136 | 1.03 |
ENST00000535559.1
|
ZNF423
|
zinc finger protein 423 |
chr5_-_160975130 | 1.03 |
ENST00000274547.2
ENST00000520240.1 ENST00000517901.1 ENST00000353437.6 |
GABRB2
|
gamma-aminobutyric acid (GABA) A receptor, beta 2 |
chr12_+_54410664 | 1.02 |
ENST00000303406.4
|
HOXC4
|
homeobox C4 |
chr20_-_56285595 | 1.00 |
ENST00000395816.3
ENST00000347215.4 |
PMEPA1
|
prostate transmembrane protein, androgen induced 1 |
chr21_-_46330545 | 1.00 |
ENST00000320216.6
ENST00000397852.1 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chr17_+_38337491 | 0.98 |
ENST00000538981.1
|
RAPGEFL1
|
Rap guanine nucleotide exchange factor (GEF)-like 1 |
chr11_+_124609742 | 0.98 |
ENST00000284292.6
|
NRGN
|
neurogranin (protein kinase C substrate, RC3) |
chr9_-_124990680 | 0.97 |
ENST00000541397.2
ENST00000560485.1 |
LHX6
|
LIM homeobox 6 |
chr1_+_171227069 | 0.97 |
ENST00000354841.4
|
FMO1
|
flavin containing monooxygenase 1 |
chr11_+_124609823 | 0.97 |
ENST00000412681.2
|
NRGN
|
neurogranin (protein kinase C substrate, RC3) |
chr19_+_18718214 | 0.95 |
ENST00000600490.1
|
TMEM59L
|
transmembrane protein 59-like |
chr11_+_64107663 | 0.95 |
ENST00000356786.5
|
CCDC88B
|
coiled-coil domain containing 88B |
chr2_+_74648848 | 0.94 |
ENST00000409791.1
ENST00000426787.1 ENST00000348227.4 |
WDR54
|
WD repeat domain 54 |
chr9_+_36136700 | 0.94 |
ENST00000396613.3
ENST00000377959.1 ENST00000377960.4 |
GLIPR2
|
GLI pathogenesis-related 2 |
chr14_+_31343747 | 0.94 |
ENST00000216361.4
ENST00000396618.3 ENST00000475087.1 |
COCH
|
cochlin |
chr14_+_31343951 | 0.93 |
ENST00000556908.1
ENST00000555881.1 ENST00000460581.2 |
COCH
|
cochlin |
chr4_+_75310851 | 0.92 |
ENST00000395748.3
ENST00000264487.2 |
AREG
|
amphiregulin |
chr12_-_49582978 | 0.90 |
ENST00000301071.7
|
TUBA1A
|
tubulin, alpha 1a |
chr5_-_176900610 | 0.89 |
ENST00000477391.2
ENST00000393565.1 ENST00000309007.5 |
DBN1
|
drebrin 1 |
chr12_+_130646999 | 0.88 |
ENST00000539839.1
ENST00000229030.4 |
FZD10
|
frizzled family receptor 10 |
chrX_-_119445306 | 0.88 |
ENST00000371369.4
ENST00000440464.1 ENST00000519908.1 |
TMEM255A
|
transmembrane protein 255A |
chr16_+_31271274 | 0.87 |
ENST00000287497.8
ENST00000544665.3 |
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit) |
chr22_+_22681656 | 0.87 |
ENST00000390291.2
|
IGLV1-50
|
immunoglobulin lambda variable 1-50 (non-functional) |
chr18_-_35145981 | 0.86 |
ENST00000420428.2
ENST00000412753.1 |
CELF4
|
CUGBP, Elav-like family member 4 |
chrX_-_153599578 | 0.85 |
ENST00000360319.4
ENST00000344736.4 |
FLNA
|
filamin A, alpha |
chr6_+_144471643 | 0.84 |
ENST00000367568.4
|
STX11
|
syntaxin 11 |
chr9_-_124991124 | 0.84 |
ENST00000394319.4
ENST00000340587.3 |
LHX6
|
LIM homeobox 6 |
chr12_-_54785074 | 0.84 |
ENST00000338010.5
ENST00000550774.1 |
ZNF385A
|
zinc finger protein 385A |
chr20_+_10199566 | 0.82 |
ENST00000430336.1
|
SNAP25
|
synaptosomal-associated protein, 25kDa |
chr19_-_6591113 | 0.82 |
ENST00000423145.3
ENST00000245903.3 |
CD70
|
CD70 molecule |
chr2_+_182322070 | 0.81 |
ENST00000233573.6
|
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) |
chr5_-_41510725 | 0.81 |
ENST00000328457.3
|
PLCXD3
|
phosphatidylinositol-specific phospholipase C, X domain containing 3 |
chr4_+_75311019 | 0.80 |
ENST00000502307.1
|
AREG
|
amphiregulin |
chr12_-_49582837 | 0.80 |
ENST00000547939.1
ENST00000546918.1 ENST00000552924.1 |
TUBA1A
|
tubulin, alpha 1a |
chr6_-_143266297 | 0.78 |
ENST00000367603.2
|
HIVEP2
|
human immunodeficiency virus type I enhancer binding protein 2 |
chr22_+_40322595 | 0.78 |
ENST00000420971.1
ENST00000544756.1 |
GRAP2
|
GRB2-related adaptor protein 2 |
chr4_+_3768075 | 0.78 |
ENST00000509482.1
ENST00000330055.5 |
ADRA2C
|
adrenoceptor alpha 2C |
chr12_-_54785054 | 0.77 |
ENST00000352268.6
ENST00000549962.1 |
ZNF385A
|
zinc finger protein 385A |
chr10_+_120967072 | 0.77 |
ENST00000392870.2
|
GRK5
|
G protein-coupled receptor kinase 5 |
chr7_+_30960915 | 0.77 |
ENST00000441328.2
ENST00000409899.1 ENST00000409611.1 |
AQP1
|
aquaporin 1 (Colton blood group) |
chr10_-_73533255 | 0.76 |
ENST00000394957.3
|
C10orf54
|
chromosome 10 open reading frame 54 |
chr9_-_136004782 | 0.76 |
ENST00000393157.3
|
RALGDS
|
ral guanine nucleotide dissociation stimulator |
chr11_-_76381029 | 0.76 |
ENST00000407242.2
ENST00000421973.1 |
LRRC32
|
leucine rich repeat containing 32 |
chrX_-_48328631 | 0.76 |
ENST00000429543.1
ENST00000317669.5 |
SLC38A5
|
solute carrier family 38, member 5 |
chr22_-_38669030 | 0.76 |
ENST00000361906.3
|
TMEM184B
|
transmembrane protein 184B |
chr5_+_102595119 | 0.75 |
ENST00000510890.1
|
C5orf30
|
chromosome 5 open reading frame 30 |
chr22_+_32340481 | 0.75 |
ENST00000397492.1
|
YWHAH
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta |
chr12_+_132312931 | 0.75 |
ENST00000360564.1
ENST00000545671.1 ENST00000545790.1 |
MMP17
|
matrix metallopeptidase 17 (membrane-inserted) |
chr12_+_111843749 | 0.75 |
ENST00000341259.2
|
SH2B3
|
SH2B adaptor protein 3 |
chr19_-_2308127 | 0.74 |
ENST00000404279.1
|
LINGO3
|
leucine rich repeat and Ig domain containing 3 |
chrX_-_119445263 | 0.74 |
ENST00000309720.5
|
TMEM255A
|
transmembrane protein 255A |
chr1_-_156217829 | 0.73 |
ENST00000356983.2
ENST00000335852.1 ENST00000340183.5 ENST00000540423.1 |
PAQR6
|
progestin and adipoQ receptor family member VI |
chr1_-_95007193 | 0.73 |
ENST00000370207.4
ENST00000334047.7 |
F3
|
coagulation factor III (thromboplastin, tissue factor) |
chr2_-_47572105 | 0.73 |
ENST00000419035.1
ENST00000448713.1 ENST00000450550.1 ENST00000413185.2 |
AC073283.4
|
AC073283.4 |
chr3_+_108541608 | 0.73 |
ENST00000426646.1
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1 |
chr3_+_108541545 | 0.73 |
ENST00000295756.6
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1 |
chr17_+_33914424 | 0.73 |
ENST00000590432.1
|
AP2B1
|
adaptor-related protein complex 2, beta 1 subunit |
chr16_+_50313426 | 0.73 |
ENST00000569265.1
|
ADCY7
|
adenylate cyclase 7 |
chr12_+_58003935 | 0.72 |
ENST00000333972.7
|
ARHGEF25
|
Rho guanine nucleotide exchange factor (GEF) 25 |
chr12_-_58131931 | 0.71 |
ENST00000547588.1
|
AGAP2
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
chr14_+_24837226 | 0.71 |
ENST00000554050.1
ENST00000554903.1 ENST00000554779.1 ENST00000250373.4 ENST00000553708.1 |
NFATC4
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4 |
chr19_+_35849723 | 0.70 |
ENST00000594310.1
|
FFAR3
|
free fatty acid receptor 3 |
chr16_+_330581 | 0.70 |
ENST00000219409.3
|
ARHGDIG
|
Rho GDP dissociation inhibitor (GDI) gamma |
chr9_-_113800317 | 0.69 |
ENST00000374431.3
|
LPAR1
|
lysophosphatidic acid receptor 1 |
chr9_-_113800341 | 0.69 |
ENST00000358883.4
|
LPAR1
|
lysophosphatidic acid receptor 1 |
chr10_+_71211212 | 0.69 |
ENST00000373290.2
|
TSPAN15
|
tetraspanin 15 |
chr19_+_54960358 | 0.68 |
ENST00000439657.1
ENST00000376514.2 ENST00000376526.4 ENST00000436479.1 |
LENG8
|
leukocyte receptor cluster (LRC) member 8 |
chr2_-_73511559 | 0.68 |
ENST00000521871.1
|
FBXO41
|
F-box protein 41 |
chr9_-_35618364 | 0.68 |
ENST00000378431.1
ENST00000378430.3 ENST00000259633.4 |
CD72
|
CD72 molecule |
chrX_-_48328551 | 0.67 |
ENST00000376876.3
|
SLC38A5
|
solute carrier family 38, member 5 |
chr1_-_201476220 | 0.67 |
ENST00000526723.1
ENST00000524951.1 |
CSRP1
|
cysteine and glycine-rich protein 1 |
chr19_+_54371114 | 0.67 |
ENST00000448420.1
ENST00000439000.1 ENST00000391770.4 ENST00000391771.1 |
MYADM
|
myeloid-associated differentiation marker |
chr5_-_41510656 | 0.66 |
ENST00000377801.3
|
PLCXD3
|
phosphatidylinositol-specific phospholipase C, X domain containing 3 |
chr15_+_65134088 | 0.66 |
ENST00000323544.4
ENST00000437723.1 |
PLEKHO2
AC069368.3
|
pleckstrin homology domain containing, family O member 2 Uncharacterized protein |
chr2_+_128403720 | 0.66 |
ENST00000272644.3
|
GPR17
|
G protein-coupled receptor 17 |
chr6_+_168399772 | 0.66 |
ENST00000443060.2
|
KIF25
|
kinesin family member 25 |
chr15_+_68871569 | 0.66 |
ENST00000566799.1
|
CORO2B
|
coronin, actin binding protein, 2B |
chr14_-_23834411 | 0.66 |
ENST00000429593.2
|
EFS
|
embryonal Fyn-associated substrate |
chr20_-_4804244 | 0.66 |
ENST00000379400.3
|
RASSF2
|
Ras association (RalGDS/AF-6) domain family member 2 |
chr2_+_173600671 | 0.66 |
ENST00000409036.1
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chr6_-_38607628 | 0.65 |
ENST00000498633.1
|
BTBD9
|
BTB (POZ) domain containing 9 |
chr17_+_76142434 | 0.65 |
ENST00000340363.5
ENST00000586999.1 |
C17orf99
|
chromosome 17 open reading frame 99 |
chr17_-_935036 | 0.65 |
ENST00000572441.1
ENST00000543210.2 |
ABR
|
active BCR-related |
chr1_-_1009683 | 0.65 |
ENST00000453464.2
|
RNF223
|
ring finger protein 223 |
chr12_+_52301175 | 0.65 |
ENST00000388922.4
|
ACVRL1
|
activin A receptor type II-like 1 |
chr1_-_156217822 | 0.64 |
ENST00000368270.1
|
PAQR6
|
progestin and adipoQ receptor family member VI |
chr17_-_40897043 | 0.64 |
ENST00000428826.2
ENST00000592492.1 ENST00000585893.1 ENST00000593214.1 ENST00000590078.1 ENST00000586382.1 ENST00000415827.2 ENST00000592743.1 ENST00000586089.1 ENST00000435174.1 |
EZH1
|
enhancer of zeste homolog 1 (Drosophila) |
chr1_-_26232522 | 0.63 |
ENST00000399728.1
|
STMN1
|
stathmin 1 |
chr2_+_182321925 | 0.63 |
ENST00000339307.4
ENST00000397033.2 |
ITGA4
|
integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor) |
chr19_-_51522955 | 0.62 |
ENST00000358789.3
|
KLK10
|
kallikrein-related peptidase 10 |
chr5_-_141030943 | 0.62 |
ENST00000522783.1
ENST00000519800.1 ENST00000435817.2 |
FCHSD1
|
FCH and double SH3 domains 1 |
chr5_-_139283982 | 0.62 |
ENST00000340391.3
|
NRG2
|
neuregulin 2 |
chr7_-_80548493 | 0.61 |
ENST00000536800.1
|
SEMA3C
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C |
chr2_-_74648702 | 0.61 |
ENST00000518863.1
|
C2orf81
|
chromosome 2 open reading frame 81 |
chr7_-_80548667 | 0.61 |
ENST00000265361.3
|
SEMA3C
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C |
chr19_+_41725140 | 0.61 |
ENST00000359092.3
|
AXL
|
AXL receptor tyrosine kinase |
chr17_-_41738931 | 0.60 |
ENST00000329168.3
ENST00000549132.1 |
MEOX1
|
mesenchyme homeobox 1 |
chr1_+_40839369 | 0.60 |
ENST00000372718.3
|
SMAP2
|
small ArfGAP2 |
chr19_+_54369608 | 0.60 |
ENST00000336967.3
|
MYADM
|
myeloid-associated differentiation marker |
chr6_-_127840453 | 0.60 |
ENST00000556132.1
|
SOGA3
|
SOGA family member 3 |
chr17_-_3867585 | 0.60 |
ENST00000359983.3
ENST00000352011.3 ENST00000397043.3 ENST00000397041.3 ENST00000397035.3 ENST00000397039.1 ENST00000309890.7 |
ATP2A3
|
ATPase, Ca++ transporting, ubiquitous |
chr16_+_57139933 | 0.59 |
ENST00000566259.1
|
CPNE2
|
copine II |
chr20_-_44539538 | 0.59 |
ENST00000372420.1
|
PLTP
|
phospholipid transfer protein |
chr2_+_173292059 | 0.59 |
ENST00000412899.1
ENST00000409532.1 |
ITGA6
|
integrin, alpha 6 |
chr7_+_86274145 | 0.59 |
ENST00000439827.1
ENST00000394720.2 ENST00000421579.1 |
GRM3
|
glutamate receptor, metabotropic 3 |
chr17_-_41739283 | 0.59 |
ENST00000393661.2
ENST00000318579.4 |
MEOX1
|
mesenchyme homeobox 1 |
chr3_+_50273625 | 0.59 |
ENST00000536647.1
|
GNAI2
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
chr16_-_4466622 | 0.58 |
ENST00000570645.1
ENST00000574025.1 ENST00000572898.1 ENST00000537233.2 ENST00000571059.1 ENST00000251166.4 |
CORO7
|
coronin 7 |
chr19_-_14247365 | 0.58 |
ENST00000592798.1
ENST00000474890.1 |
ASF1B
|
anti-silencing function 1B histone chaperone |
chr15_-_74043816 | 0.58 |
ENST00000379822.4
|
C15orf59
|
chromosome 15 open reading frame 59 |
chr2_+_172378757 | 0.58 |
ENST00000409484.1
ENST00000321348.4 ENST00000375252.3 |
CYBRD1
|
cytochrome b reductase 1 |
chr10_-_30348439 | 0.58 |
ENST00000375377.1
|
KIAA1462
|
KIAA1462 |
chr2_+_128403439 | 0.57 |
ENST00000544369.1
|
GPR17
|
G protein-coupled receptor 17 |
chr1_-_156217875 | 0.57 |
ENST00000292291.5
|
PAQR6
|
progestin and adipoQ receptor family member VI |
chr1_-_157522180 | 0.57 |
ENST00000356953.4
ENST00000368188.2 ENST00000368190.3 ENST00000368189.3 |
FCRL5
|
Fc receptor-like 5 |
chr10_+_72432559 | 0.56 |
ENST00000373208.1
ENST00000373207.1 |
ADAMTS14
|
ADAM metallopeptidase with thrombospondin type 1 motif, 14 |
chr10_-_25241499 | 0.56 |
ENST00000376378.1
ENST00000376376.3 ENST00000320152.6 |
PRTFDC1
|
phosphoribosyl transferase domain containing 1 |
chr12_-_49582593 | 0.56 |
ENST00000295766.5
|
TUBA1A
|
tubulin, alpha 1a |
chr16_-_75529273 | 0.56 |
ENST00000390664.2
|
CHST6
|
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6 |
chr2_+_173292390 | 0.56 |
ENST00000442250.1
ENST00000458358.1 ENST00000409080.1 |
ITGA6
|
integrin, alpha 6 |
chr1_-_111682813 | 0.55 |
ENST00000539140.1
|
DRAM2
|
DNA-damage regulated autophagy modulator 2 |
chr1_-_149889382 | 0.55 |
ENST00000369145.1
ENST00000369146.3 |
SV2A
|
synaptic vesicle glycoprotein 2A |
chr14_+_96505659 | 0.54 |
ENST00000555004.1
|
C14orf132
|
chromosome 14 open reading frame 132 |
chr17_+_30593195 | 0.54 |
ENST00000431505.2
ENST00000269051.4 ENST00000538145.1 |
RHBDL3
|
rhomboid, veinlet-like 3 (Drosophila) |
chr19_+_48958766 | 0.54 |
ENST00000342291.2
|
KCNJ14
|
potassium inwardly-rectifying channel, subfamily J, member 14 |
chr12_-_48213568 | 0.54 |
ENST00000080059.7
ENST00000354334.3 ENST00000430670.1 ENST00000552960.1 ENST00000440293.1 |
HDAC7
|
histone deacetylase 7 |
chr19_-_45579762 | 0.53 |
ENST00000303809.2
|
ZNF296
|
zinc finger protein 296 |
chr10_+_90672113 | 0.53 |
ENST00000371922.1
|
STAMBPL1
|
STAM binding protein-like 1 |
chr17_+_61851157 | 0.53 |
ENST00000578681.1
ENST00000583590.1 |
DDX42
|
DEAD (Asp-Glu-Ala-Asp) box helicase 42 |
chr2_-_161349909 | 0.53 |
ENST00000392753.3
|
RBMS1
|
RNA binding motif, single stranded interacting protein 1 |
chr14_+_23790655 | 0.53 |
ENST00000397276.2
|
PABPN1
|
poly(A) binding protein, nuclear 1 |
chr20_+_10199468 | 0.53 |
ENST00000254976.2
ENST00000304886.2 |
SNAP25
|
synaptosomal-associated protein, 25kDa |
chr2_+_173292280 | 0.53 |
ENST00000264107.7
|
ITGA6
|
integrin, alpha 6 |
chr19_+_54369434 | 0.52 |
ENST00000421337.1
|
MYADM
|
myeloid-associated differentiation marker |
chr2_+_173292301 | 0.52 |
ENST00000264106.6
ENST00000375221.2 ENST00000343713.4 |
ITGA6
|
integrin, alpha 6 |
chr14_+_65879668 | 0.52 |
ENST00000553924.1
ENST00000358307.2 ENST00000557338.1 ENST00000554610.1 |
FUT8
|
fucosyltransferase 8 (alpha (1,6) fucosyltransferase) |
chr1_+_157963391 | 0.52 |
ENST00000359209.6
ENST00000416935.2 |
KIRREL
|
kin of IRRE like (Drosophila) |
chr5_+_102594725 | 0.52 |
ENST00000515669.1
|
C5orf30
|
chromosome 5 open reading frame 30 |
chr1_+_203765437 | 0.52 |
ENST00000550078.1
|
ZBED6
|
zinc finger, BED-type containing 6 |
chr7_+_50344289 | 0.52 |
ENST00000413698.1
ENST00000359197.5 ENST00000331340.3 ENST00000357364.4 ENST00000343574.5 ENST00000349824.4 ENST00000346667.4 ENST00000440768.2 |
IKZF1
|
IKAROS family zinc finger 1 (Ikaros) |
chr21_+_19617140 | 0.51 |
ENST00000299295.2
ENST00000338326.3 |
CHODL
|
chondrolectin |
chr2_+_173600514 | 0.51 |
ENST00000264111.6
|
RAPGEF4
|
Rap guanine nucleotide exchange factor (GEF) 4 |
chr7_+_17338239 | 0.51 |
ENST00000242057.4
|
AHR
|
aryl hydrocarbon receptor |
chr19_-_46476791 | 0.51 |
ENST00000263257.5
|
NOVA2
|
neuro-oncological ventral antigen 2 |
chr16_+_29985503 | 0.51 |
ENST00000543033.1
ENST00000279394.3 |
TAOK2
|
TAO kinase 2 |
chr11_-_62313090 | 0.50 |
ENST00000528508.1
ENST00000533365.1 |
AHNAK
|
AHNAK nucleoprotein |
chr6_-_41908428 | 0.50 |
ENST00000505064.1
|
CCND3
|
cyclin D3 |
chr1_-_161039753 | 0.49 |
ENST00000368015.1
|
ARHGAP30
|
Rho GTPase activating protein 30 |
chr12_+_52300692 | 0.49 |
ENST00000551576.1
|
ACVRL1
|
activin A receptor type II-like 1 |
chr19_-_10047219 | 0.49 |
ENST00000264833.4
|
OLFM2
|
olfactomedin 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 1.3 | GO:1990926 | short-term synaptic potentiation(GO:1990926) |
0.6 | 2.5 | GO:1990927 | negative regulation of membrane invagination(GO:1905154) calcium ion regulated lysosome exocytosis(GO:1990927) |
0.6 | 3.5 | GO:0030421 | defecation(GO:0030421) |
0.5 | 1.4 | GO:0050904 | diapedesis(GO:0050904) |
0.4 | 1.2 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.4 | 1.9 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.4 | 3.0 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.4 | 1.1 | GO:0045082 | positive regulation of interleukin-10 biosynthetic process(GO:0045082) positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.3 | 2.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.3 | 0.9 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.3 | 0.8 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
0.3 | 1.4 | GO:1904566 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.3 | 0.8 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
0.2 | 0.7 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.2 | 1.6 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.2 | 1.8 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 0.4 | GO:0051586 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.2 | 0.7 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
0.2 | 1.8 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.2 | 1.2 | GO:0001757 | somite specification(GO:0001757) sclerotome development(GO:0061056) |
0.2 | 2.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.2 | 0.8 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.2 | 0.2 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
0.2 | 0.8 | GO:0035625 | negative regulation of epinephrine secretion(GO:0032811) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.2 | 3.1 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.2 | 0.6 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.2 | 0.9 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.2 | 0.7 | GO:0002879 | positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.2 | 1.5 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.2 | 1.5 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
0.2 | 0.6 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.2 | 1.1 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.2 | 0.9 | GO:2000669 | negative regulation of dendritic cell apoptotic process(GO:2000669) |
0.2 | 0.5 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.2 | 0.8 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 0.5 | GO:2000308 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
0.1 | 0.9 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.1 | 0.7 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.1 | 0.4 | GO:1904596 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
0.1 | 0.4 | GO:0045799 | positive regulation of chromatin assembly or disassembly(GO:0045799) |
0.1 | 0.7 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 0.4 | GO:0072616 | interleukin-18 secretion(GO:0072616) |
0.1 | 1.6 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.1 | 0.5 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
0.1 | 1.8 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.1 | 0.6 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.1 | 1.0 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 1.0 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.1 | 5.7 | GO:0035640 | exploration behavior(GO:0035640) |
0.1 | 1.1 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 1.2 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
0.1 | 0.5 | GO:0014052 | regulation of gamma-aminobutyric acid secretion(GO:0014052) |
0.1 | 1.0 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.1 | 1.3 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.1 | 1.6 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.1 | 0.4 | GO:1904978 | regulation of endosome organization(GO:1904978) |
0.1 | 0.3 | GO:0050822 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
0.1 | 1.1 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.4 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.1 | 0.3 | GO:0002352 | B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.1 | 1.5 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.1 | 2.0 | GO:0061339 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.1 | 0.4 | GO:0044691 | tooth eruption(GO:0044691) |
0.1 | 0.6 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 1.9 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 1.2 | GO:0072103 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.1 | 0.6 | GO:0043314 | negative regulation of neutrophil degranulation(GO:0043314) |
0.1 | 1.4 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.3 | GO:0032053 | ciliary basal body organization(GO:0032053) positive regulation of protein localization to cilium(GO:1903566) |
0.1 | 0.8 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 1.3 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 1.2 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.8 | GO:0042756 | drinking behavior(GO:0042756) |
0.1 | 1.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.1 | 0.2 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.1 | 0.4 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.1 | 0.3 | GO:1901963 | glial cell fate determination(GO:0007403) canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation(GO:0061324) regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901963) regulation of chromatin-mediated maintenance of transcription(GO:1904499) positive regulation of chromatin-mediated maintenance of transcription(GO:1904501) regulation of euchromatin binding(GO:1904793) |
0.1 | 0.3 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.1 | 0.4 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.1 | 0.6 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.5 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.1 | 0.5 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.1 | 1.9 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
0.1 | 0.2 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
0.1 | 0.6 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.5 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.0 | 0.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.3 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.0 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.0 | 0.4 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.0 | 0.6 | GO:0035290 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
0.0 | 0.5 | GO:0006983 | ER overload response(GO:0006983) |
0.0 | 1.0 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.0 | 0.8 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.3 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) |
0.0 | 0.7 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.0 | 0.4 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.0 | 0.8 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 1.0 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.3 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.0 | 0.2 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.2 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
0.0 | 0.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.0 | 0.7 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.0 | 0.6 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.0 | 0.2 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.0 | 1.0 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.6 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.0 | 0.2 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.0 | 0.8 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 | 0.8 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.9 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.0 | 1.2 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.9 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.4 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 4.8 | GO:0042100 | B cell proliferation(GO:0042100) |
0.0 | 0.2 | GO:0002254 | kinin cascade(GO:0002254) plasma kallikrein-kinin cascade(GO:0002353) |
0.0 | 0.7 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.0 | 0.5 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.3 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.0 | 0.4 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
0.0 | 0.4 | GO:0035437 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.0 | 0.4 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.1 | GO:0015891 | iron chelate transport(GO:0015688) siderophore transport(GO:0015891) |
0.0 | 0.5 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.0 | 0.1 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
0.0 | 0.1 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
0.0 | 0.4 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.2 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) histone H2A phosphorylation(GO:1990164) |
0.0 | 0.5 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.0 | 0.3 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.0 | 0.6 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.0 | 3.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.4 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.2 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.0 | 0.3 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 1.2 | GO:0008038 | neuron recognition(GO:0008038) |
0.0 | 0.3 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.0 | 0.3 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.7 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.0 | 0.2 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.0 | 0.3 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.0 | 0.7 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.1 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.6 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
0.0 | 0.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.6 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 1.7 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.0 | 1.0 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.0 | 0.2 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
0.0 | 0.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.7 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.0 | 0.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.0 | 0.2 | GO:1990034 | cellular response to corticosterone stimulus(GO:0071386) calcium ion export from cell(GO:1990034) |
0.0 | 1.2 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 1.2 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.2 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
0.0 | 0.4 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.0 | 0.1 | GO:0046121 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) beta-alanine metabolic process(GO:0019482) thymine metabolic process(GO:0019859) uracil metabolic process(GO:0019860) deoxyribonucleoside catabolic process(GO:0046121) |
0.0 | 1.5 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 1.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.8 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
0.0 | 0.0 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.0 | 2.9 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 1.0 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.0 | 0.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.0 | 0.1 | GO:0034465 | response to carbon monoxide(GO:0034465) |
0.0 | 0.3 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.0 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.0 | 0.2 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.0 | 0.0 | GO:0030047 | actin modification(GO:0030047) |
0.0 | 1.0 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 1.6 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.0 | 0.3 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.0 | 3.6 | GO:0007162 | negative regulation of cell adhesion(GO:0007162) |
0.0 | 0.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.4 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.6 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 0.5 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.1 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.0 | 0.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.6 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.3 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.1 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.0 | 1.1 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 4.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.5 | 2.2 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
0.4 | 2.5 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.3 | 1.4 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.3 | 0.8 | GO:0020003 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
0.2 | 1.9 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
0.2 | 0.9 | GO:0031523 | Myb complex(GO:0031523) |
0.2 | 1.3 | GO:0070032 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex(GO:0070032) |
0.2 | 0.8 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 1.0 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.5 | GO:0000811 | GINS complex(GO:0000811) |
0.1 | 1.9 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 0.5 | GO:0008043 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
0.1 | 0.5 | GO:0034753 | nuclear aryl hydrocarbon receptor complex(GO:0034753) |
0.1 | 0.8 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 1.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 0.5 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.1 | 0.3 | GO:0005607 | laminin-2 complex(GO:0005607) |
0.1 | 0.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 1.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.0 | 0.7 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.0 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.9 | GO:0033643 | host cell part(GO:0033643) |
0.0 | 0.3 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.0 | 1.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.8 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.0 | 0.3 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.3 | GO:0042825 | TAP complex(GO:0042825) |
0.0 | 1.1 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.0 | 0.2 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 0.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.0 | 0.3 | GO:0070369 | Scrib-APC-beta-catenin complex(GO:0034750) beta-catenin-TCF7L2 complex(GO:0070369) |
0.0 | 0.6 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.0 | 1.0 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.0 | 1.0 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.9 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 19.0 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.0 | 1.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.5 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 2.6 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.2 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.1 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.0 | 0.4 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 1.2 | GO:0019814 | immunoglobulin complex(GO:0019814) |
0.0 | 0.4 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.3 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 0.7 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 0.6 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.0 | 0.6 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.9 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.3 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.0 | 0.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 4.6 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.0 | 0.4 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.0 | 0.2 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 2.6 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.4 | GO:0008091 | spectrin(GO:0008091) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.7 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 1.3 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 2.1 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.5 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 0.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 1.0 | GO:0043235 | receptor complex(GO:0043235) |
0.0 | 1.2 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.0 | 1.7 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 0.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.3 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 2.6 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.0 | 0.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 0.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.5 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 0.1 | GO:0030054 | cell junction(GO:0030054) |
0.0 | 0.7 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.2 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.0 | 0.6 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 1.9 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.4 | 2.2 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
0.4 | 1.2 | GO:0008841 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
0.3 | 0.8 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.3 | 0.8 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.3 | 0.8 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
0.3 | 0.8 | GO:0070123 | transforming growth factor beta receptor activity, type III(GO:0070123) |
0.2 | 0.8 | GO:0098808 | mRNA cap binding(GO:0098808) |
0.2 | 1.4 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.2 | 1.6 | GO:0042835 | BRE binding(GO:0042835) |
0.2 | 1.3 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 2.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.2 | 0.5 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.1 | 1.0 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 0.4 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
0.1 | 1.9 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.1 | 0.5 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.1 | 1.0 | GO:0005237 | inhibitory extracellular ligand-gated ion channel activity(GO:0005237) |
0.1 | 0.5 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.1 | 1.4 | GO:0070915 | lysophosphatidic acid binding(GO:0035727) lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.9 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.1 | 1.0 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.1 | 0.4 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.1 | 0.4 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.1 | 0.6 | GO:0001641 | group II metabotropic glutamate receptor activity(GO:0001641) |
0.1 | 0.6 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.1 | 0.3 | GO:0051908 | double-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0051908) |
0.1 | 0.3 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
0.1 | 1.4 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.1 | 0.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.1 | 0.3 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
0.1 | 0.5 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.1 | 3.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.1 | 1.3 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.4 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 0.3 | GO:0030305 | beta-glucuronidase activity(GO:0004566) heparanase activity(GO:0030305) |
0.1 | 0.4 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.1 | 2.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.5 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 1.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.3 | GO:0015433 | peptide antigen-transporting ATPase activity(GO:0015433) |
0.1 | 0.7 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.1 | 0.5 | GO:0044547 | DNA topoisomerase binding(GO:0044547) |
0.1 | 0.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 1.9 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.0 | 1.5 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 1.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 1.1 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.9 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.2 | GO:0004307 | diacylglycerol cholinephosphotransferase activity(GO:0004142) ethanolaminephosphotransferase activity(GO:0004307) |
0.0 | 0.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 0.6 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 2.4 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.2 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.2 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.0 | 0.9 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 1.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 1.1 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.0 | 0.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.0 | 0.5 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.6 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.0 | 0.2 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.0 | 9.2 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 0.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.0 | 0.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.0 | 1.2 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.5 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.8 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.3 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.0 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 2.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.3 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.0 | 0.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.2 | GO:1902444 | riboflavin binding(GO:1902444) |
0.0 | 0.3 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.0 | 0.6 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.6 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.5 | GO:0044548 | S100 protein binding(GO:0044548) |
0.0 | 1.7 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.4 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.0 | 1.2 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.0 | 0.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
0.0 | 0.8 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.0 | 0.5 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.7 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.7 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 1.4 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.5 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 1.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 2.5 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 1.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.6 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 0.4 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.4 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.0 | 4.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.0 | 2.2 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.4 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.2 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.0 | 0.4 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 0.7 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.8 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.7 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.0 | 0.3 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 4.2 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 0.1 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 0.3 | GO:0051400 | BH domain binding(GO:0051400) |
0.0 | 1.4 | GO:0016279 | protein-lysine N-methyltransferase activity(GO:0016279) |
0.0 | 0.2 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.0 | 0.5 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 0.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.0 | 2.0 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.4 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.5 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.0 | 0.4 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 1.4 | GO:0005178 | integrin binding(GO:0005178) |
0.0 | 1.4 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 5.3 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.8 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 1.4 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.0 | 0.4 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.4 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.0 | 0.3 | GO:0010857 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) calcium-dependent protein kinase activity(GO:0010857) |
0.0 | 0.5 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.0 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.0 | 0.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.8 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.2 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 1.6 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.8 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 3.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 8.5 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.8 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 3.3 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.0 | 2.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 2.5 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 1.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 1.9 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.0 | 4.9 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 2.2 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.3 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 2.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.2 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.7 | PID EPO PATHWAY | EPO signaling pathway |
0.0 | 0.9 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.4 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 1.2 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 1.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 1.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 2.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.8 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.2 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 0.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.0 | 0.6 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 1.4 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.0 | 0.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.7 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 0.4 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.4 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.0 | 0.7 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.3 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 0.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 0.6 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 1.5 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.1 | 1.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 2.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 1.6 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 2.6 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 4.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 0.8 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 1.3 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.0 | 7.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 1.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 2.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 1.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.0 | 0.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.0 | 0.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 1.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.5 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 0.2 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.0 | 0.8 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.0 | 1.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 1.0 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
0.0 | 0.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 0.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.6 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.6 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.9 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 1.1 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.0 | 0.9 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.0 | 1.1 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.0 | 4.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.6 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.4 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.0 | 0.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 1.4 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.7 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.2 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.0 | 0.2 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 1.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 1.8 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.0 | 0.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.3 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |